Exome Chip Analysis Identifies Low-Frequency and Rare Variants in MRPL38 for White Matter Hyperintensities on Brain Magnetic Resonance Imaging

Background and Purpose— White matter hyperintensities (WMH) on brain magnetic resonance imaging are typical signs of cerebral small vessel disease and may indicate various preclinical, age-related neurological disorders, such as stroke. Though WMH are highly heritable, known common variants explain a small proportion of the WMH variance. The contribution of low-frequency/rare coding variants to WMH burden has not been explored. Methods— In the discovery sample we recruited 20 719 stroke/dementia-free adults from 13 population-based cohort studies within the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium, among which 17 790 were of European ancestry and 2929 of African ancestry. We genotyped these participants at ≈250 000 mostly exonic variants with Illumina HumanExome BeadChip arrays. We performed ethnicity-specific linear regression on rank-normalized WMH in each study separately, which were then combined in meta-analyses to test for association with single variants and genes aggregating the effects of putatively functional low-frequency/rare variants. We then sought replication of the top findings in 1192 adults (European ancestry) with whole exome/genome sequencing data from 2 independent studies. Results— At 17q25, we confirmed the association of multiple common variants in TRIM65, FBF1, and ACOX1 (P<6×10−7). We also identified a novel association with 2 low-frequency nonsynonymous variants in MRPL38 (lead, rs34136221; PEA=4.5×10−8) partially independent of known common signal (PEA(conditional)=1.4×10−3). We further identified a locus at 2q33 containing common variants in NBEAL1, CARF, and WDR12 (lead, rs2351524; Pall=1.9×10−10). Although our novel findings were not replicated because of limited power and possible differences in study design, meta-analysis of the discovery and replication samples yielded stronger association for the 2 low-frequency MRPL38 variants (Prs34136221=2.8×10−8). Conclusions— Both common and low-frequency/rare functional variants influence WMH. Larger replication and experimental follow-up are essential to confirm our findings and uncover the biological causal mechanisms of age-related WMH.

[1]  M. Fornage,et al.  Whole genome sequence analyses of brain imaging measures in the Framingham Study , 2018, Neurology.

[2]  Min A. Jhun,et al.  Multiethnic Exome-Wide Association Study of Subclinical Atherosclerosis , 2016, Circulation. Cardiovascular genetics.

[3]  M. Filippi,et al.  Carotid atherosclerosis, silent ischemic brain damage and brain atrophy: A systematic review and meta-analysis. , 2016, International journal of cardiology.

[4]  M. Feolo,et al.  Rapid evaluation of phenotypes, SNPs and results through the dbGaP CHARGE Summary Results site , 2016, Nature Genetics.

[5]  Jonathan P. Beauchamp,et al.  Genetic variants associated with subjective well-being, depressive symptoms and neuroticism identified through genome-wide analyses , 2016, Nature Genetics.

[6]  Christos Davatzikos,et al.  White matter hyperintensities and imaging patterns of brain ageing in the general population. , 2016, Brain : a journal of neurology.

[7]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, bioRxiv.

[8]  Kaitlin M. Fitzpatrick,et al.  Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke , 2016, Neurology.

[9]  K. Arai,et al.  Astrocytes Promote Oligodendrogenesis after White Matter Damage via Brain-Derived Neurotrophic Factor , 2015, The Journal of Neuroscience.

[10]  J. Marrugat,et al.  Association Between Coronary Artery Disease Genetic Variants and Subclinical Atherosclerosis: An Association Study and Meta-analysis. , 2015, Revista espanola de cardiologia.

[11]  J. Marrugat,et al.  Asociación entre variantes genéticas de enfermedad coronaria y aterosclerosis subclínica: estudio de asociación y metanálisis , 2015 .

[12]  Lorna M. Lopez,et al.  Multiethnic Genome-Wide Association Study of Cerebral White Matter Hyperintensities on MRI , 2015, Circulation. Cardiovascular genetics.

[13]  Joanna M. Wardlaw,et al.  Genes From a Translational Analysis Support a Multifactorial Nature of White Matter Hyperintensities , 2015, Stroke.

[14]  Kaitlin M. Fitzpatrick,et al.  Genetic Architecture of White Matter Hyperintensities Differs in Hypertensive and Nonhypertensive Ischemic Stroke , 2015, Stroke.

[15]  C. Brayne,et al.  Oxidative Glial Cell Damage Associated with White Matter Lesions in the Aging Human Brain , 2014, Brain pathology.

[16]  Alan Brown,et al.  Structure of the large ribosomal subunit from human mitochondria , 2014, Science.

[17]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[18]  Chu-Chung Huang,et al.  Effect of BDNF Val66Met polymorphism on regional white matter hyperintensities and cognitive function in elderly males without dementia , 2014, Psychoneuroendocrinology.

[19]  E. Boerwinkle,et al.  dbNSFP v2.0: A Database of Human Non‐synonymous SNVs and Their Functional Predictions and Annotations , 2013, Human mutation.

[20]  Eric Boerwinkle,et al.  Best Practices and Joint Calling of the HumanExome BeadChip: The CHARGE Consortium , 2013, PloS one.

[21]  A. Schäffer,et al.  The BEACH Is Hot: A LYST of Emerging Roles for BEACH‐Domain Containing Proteins in Human Disease , 2013, Traffic.

[22]  Kaitlin M. Fitzpatrick,et al.  17q25 Locus Is Associated With White Matter Hyperintensity Volume in Ischemic Stroke, But Not With Lacunar Stroke Status , 2013, Stroke.

[23]  K. Kohara,et al.  Association of Chr17q25 with cerebral white matter hyperintensities and cognitive impairment: the J‐SHIPP study , 2013, European journal of neurology.

[24]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[25]  J. Danesh,et al.  Large-scale association analysis identifies new risk loci for coronary artery disease , 2013 .

[26]  Benjamin S Aribisala,et al.  Close Correlation between Quantitative and Qualitative Assessments of White Matter Lesions , 2012, Neuroepidemiology.

[27]  Eurie L. Hong,et al.  Annotation of functional variation in personal genomes using RegulomeDB , 2012, Genome research.

[28]  H. Lassmann,et al.  NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury , 2012 .

[29]  Jean-Baptiste Cazier,et al.  Large Scale Association Analysis Identifies Three Susceptibility Loci for Coronary Artery Disease , 2011, PloS one.

[30]  Benjamin F. J. Verhaaren,et al.  Replication Study of Chr17q25 With Cerebral White Matter Lesion Volume , 2011, Stroke.

[31]  M. Fornage,et al.  Genome‐wide association studies of cerebral white matter lesion burden , 2011, Annals of neurology.

[32]  Thomas W. Mühleisen,et al.  Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease , 2011, Nature Genetics.

[33]  H. Markus,et al.  The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[34]  R. Rodriguiz,et al.  Reduced Cortical BDNF Expression and Aberrant Memory in Carf Knock-Out Mice , 2010, The Journal of Neuroscience.

[35]  D. Goldstein,et al.  Uncovering the roles of rare variants in common disease through whole-genome sequencing , 2010, Nature Reviews Genetics.

[36]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[37]  C. Jack,et al.  Blood Pressure and White-Matter Disease Progression in a Biethnic Cohort: Atherosclerosis Risk in Communities (ARIC) Study , 2010, Stroke.

[38]  Alberto Piazza,et al.  Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants , 2009, Nature Genetics.

[39]  K. Lunetta,et al.  Methods in Genetics and Clinical Interpretation Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Design of Prospective Meta-Analyses of Genome-Wide Association Studies From 5 Cohorts , 2010 .

[40]  W. Bodmer,et al.  Common and rare variants in multifactorial susceptibility to common diseases , 2008, Nature Genetics.

[41]  E. Kremmer,et al.  Mammalian WDR12 is a novel member of the Pes1–Bop1 complex and is required for ribosome biogenesis and cell proliferation , 2005, The Journal of cell biology.

[42]  Lenore J Launer,et al.  Epidemiology of White Matter Lesions , 2004, Topics in magnetic resonance imaging : TMRI.

[43]  Norman J Beauchamp,et al.  White Matter Hyperintensity on Cranial Magnetic Resonance Imaging: A Predictor of Stroke , 2004, Stroke.

[44]  Charles DeCarli,et al.  Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study , 2004, Stroke.

[45]  Haipeng Cheng,et al.  Identification and characterization of NBEAL1, a novel human neurobeachin-like 1 protein gene from fetal brain, which is up regulated in glioma. , 2004, Brain research. Molecular brain research.

[46]  M. Fornage,et al.  Heritability of Leukoaraiosis in Hypertensive Sibships , 2004, Hypertension.

[47]  Leonardo Pantoni,et al.  Pathophysiology of Cerebral Small Vessels in Vascular Cognitive Impairment , 2003, International Psychogeriatrics.

[48]  Michael E. Greenberg,et al.  A Calcium-Responsive Transcription Factor, CaRF, that Regulates Neuronal Activity-Dependent Expression of BDNF , 2002, Neuron.

[49]  B L Miller,et al.  Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. , 1998, Stroke.

[50]  J. Garcìa,et al.  Pathogenesis of leukoaraiosis: a review. , 1997, Stroke.

[51]  L. Fried,et al.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. , 1996, Stroke.

[52]  A Hofman,et al.  Cerebral white matter lesions and atherosclerosis in the Rotterdam Study , 1993, The Lancet.

[53]  H. M. Cheng,et al.  Raf kinase inhibitory protein (RKIP): functional pleiotropy in the mammalian brain. , 2014, Critical reviews in oncogenesis.

[54]  Boer,et al.  Genome-wide association studies of cerebral white matter lesion burden: the CHARGE Consortium , 2011 .

[55]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[56]  E. V. van Dijk,et al.  Frequency of white matter lesions and silent lacunar infarcts. , 2002, Journal of neural transmission. Supplementum.

[57]  R. Horvath,et al.  Newcastle University Eprints Date Deposited: 11 Mitochondria: Impaired Mitochondrial Translation in Human Disease , 2022 .